Point72 Asset
View Older Stories View More Recent Stories
-
Form SCHEDULE 13G/A VNET Group, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Sweetgreen, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A SUTRO BIOPHARMA, INC. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Q32 Bio Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A POWER SOLUTIONS INTERNAT Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Janux Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A HMH Holding Inc Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Design Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Atara Biotherapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A AIB Data Centers Inc. Filed by: Point72 Asset Management, L.P.
-
Steve Cohen’s Point72 hedge fund down 3.3% in July; up 10.9% year to date – Reuters
-
Form SCHEDULE 13G Evommune, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G Perceptive Capital Solut Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G BlockchAIn Digital Infra Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G Design Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G Avalo Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G POWER SOLUTIONS INTERNAT Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G Sweetgreen, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A IO Biotech, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A OKYO Pharma Ltd Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Q32 Bio Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A PRECIGEN, INC. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Korro Bio, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Forte Biosciences, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Edesa Biotech, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Design Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A CYBIN INC. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Invivyd, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A KalVista Pharmaceuticals Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Xilio Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Tonix Pharmaceuticals Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Relay Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A ANAPTYSBIO, INC Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Ovid Therapeutics Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Immunome Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Damora Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A C4 Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A iBio, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Century Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Syndax Pharmaceuticals Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A PALATIN TECHNOLOGIES Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Oric Pharmaceuticals, Filed by: Point72 Asset Management, L.P.
-
Form 13F-HR Point72 Asset Management For: Mar 31
-
Form SCHEDULE 13G/A Black Rock Coffee Bar, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Praxis Precision Medicin Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Lionsgate Studios Corp. Filed by: Point72 Asset Management, L.P.

